Prevalence of and Risk Factors for Depressive Symptoms and Antidepressant Use in Young Australian Women: A Cross-Sectional Study.

Background: Despite the high prevalence of depression among adult women, the proportion of reproductive-aged women with moderate or severe depressive symptoms is uncertain, as is the proportion taking antidepressant medication. We report the prevalence of depressive symptoms in young Australian women, risk factors for depressive symptoms, and psychoactive drug use. Methods: An online survey was completed by population-based sample of 6,986 Australian women, aged 18-39 years, recruited from November 2016 to July 2017. Depressive symptoms were assessed by the Beck Depression Inventory-II, and psychotropic medication use was self-reported. Results: The prevalences of moderate and severe depressive symptoms were 15.0% (95% confidence interval [CI] 14.1%-15.8%) and 14.8% (95% CI 14.0%-15.7%), respectively. Housing insecurity was associated with over a twofold likelihood of moderate to severe depressive symptoms, whereas being parous or at least 25 years of age was protective. Use of any psychotropic medication was reported by 16.3% (95% CI 15.4%-17.2%). A previous cancer diagnosis was the strongest risk factor for current antidepressant use, whereas compared with being of European ancestry, being Asian or of another ancestry was associated with a lower likelihood of antidepressant use. Conclusions: The prevalence of moderate to severe depressive symptoms among young Australian women is alarming. Prevention strategies targeting the sociodemographic circumstances underpinning the identified risk factors are urgently needed.

[1]  P. Villeneuve,et al.  Self-reported health impacts of caregiving by age and income among participants of the Canadian 2012 General Social Survey. , 2019, Health promotion and chronic disease prevention in Canada : research, policy and practice.

[2]  S. Davis,et al.  Challenges in recruitment to an epidemiological study of young Australian women: the Grollo‐Ruzzene Foundation Young Women’s Health Study , 2019, Australian and New Zealand journal of public health.

[3]  Z. Aitken,et al.  The 'double precarity' of employment insecurity and unaffordable housing and its impact on mental health. , 2019, Social science & medicine.

[4]  S. Chapman,et al.  Depression and state anxiety scores during assisted reproductive treatment are associated with outcome: a meta-analysis. , 2018, Reproductive biomedicine online.

[5]  L. Williams,et al.  The Population Mean Mood Predicts The Prevalence of Depression in an Australian Context , 2018, The Australian and New Zealand journal of psychiatry.

[6]  S. Davis,et al.  Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms. , 2017, Journal of women's health.

[7]  J. Bongaarts,et al.  Trends in the age at reproductive transitions in the developing world: The role of education , 2017, Population studies.

[8]  C. Davey,et al.  The unfulfilled promise of the antidepressant medications , 2016, The Medical journal of Australia.

[9]  M. Lader,et al.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders , 2016, Current Psychiatry Reports.

[10]  S. Davis,et al.  Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife. , 2015, Maturitas.

[11]  E. Banks,et al.  Characteristics of antidepressant medication users in a cohort of mid-age and older Australians , 2015, The Australian and New Zealand journal of psychiatry.

[12]  M. Toombs,et al.  A systematic review: Identifying the prevalence rates of psychiatric disorder in Australia’s Indigenous populations , 2015, The Australian and New Zealand journal of psychiatry.

[13]  Asaduzzaman Khan,et al.  Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women , 2014, Social Psychiatry and Psychiatric Epidemiology.

[14]  M. Sammel,et al.  Longitudinal pattern of depressive symptoms around natural menopause. , 2014, JAMA psychiatry.

[15]  I. McGregor,et al.  Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011 , 2013, The Australian and New Zealand journal of psychiatry.

[16]  N. Titov,et al.  Psychometric Comparison of the PHQ-9 and BDI-II for Measuring Response during Treatment of Depression , 2011, Cognitive behaviour therapy.

[17]  W. Hall,et al.  Patterns of Antipsychotic Medication Use in Australia 2002–2007 , 2010, The Australian and New Zealand journal of psychiatry.

[18]  S. Tett,et al.  A comparison of antidepressant use in Nova Scotia, Canada and Australia , 2008, Pharmacoepidemiology and drug safety.

[19]  S. Patten,et al.  Reasons for antidepressant prescriptions in Canada , 2007, Pharmacoepidemiology and drug safety.

[20]  Christina Lee,et al.  Correlates of depressive symptoms in a representative sample of young Australian women , 2004 .

[21]  P. Mitchell,et al.  Recent trends in the use of antidepressant drugs in Australia, 1990–1998 , 2000, The Medical journal of Australia.

[22]  G. Andrews,et al.  Australia's Mental Health: An Overview of the General Population Survey* , 2000, The Australian and New Zealand journal of psychiatry.

[23]  Heinrich Sauer,et al.  On the Validity of the Beck Depression Inventory , 1998, Psychopathology.

[24]  C. Dowrick,et al.  Outcomes of Depression International Network (ODIN) , 1998, British Journal of Psychiatry.